Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
Pancreatic cancer is a fatal malignant neoplasm with infrequent signs and symptoms until a progressive stage. In 2020, GLOBOCAN reported that pancreatic cancer accounts for 4.7% of all cancer deaths. Despite the availability of standard chemotherapy regimens for treatment, the survival benefits are...
Saved in:
Main Authors: | Stanslas, Johnson, Islam, Mohammad Kaisarul, Selvarajoo, Nityaa, Sagineedu, Sreenivasa Rao, Lian, Ho Kok, Lim, Jonathan Chee Woei |
---|---|
Format: | Article |
Published: |
Bentham Science Publishers
2022
|
Online Access: | http://psasir.upm.edu.my/id/eprint/102744/ https://www.eurekaselect.com/article/121841 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022) -
More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro
by: Yuan, Han Teh, et al.
Published: (2023) -
Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer
by: Islam, Mohammad Kaisarul, et al.
Published: (2021) -
Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review
by: Bagalkotkar, Gururaj, et al.
Published: (2006) -
Andrographolide induces cell cycle arrest and apoptosis in PC-3 prostate cancer cells.
by: Hui, Chyn Wong, et al.
Published: (2011)